Mergers and Acquisitions

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

To assess potential risks and impacts of a merger due with the client’s company, initiated to develop business advantages through consolidation of personnel, technology and intellectual property.

Problem Statement:

A large medical device client, based in the United States with capabilities in drug delivery medical devices, involved DelveInsight to assess the potential risks and benefits of a merger being evaluated to further the goal of becoming market leaders in the niche area of drug delivery through novel technology. The client wanted to include certain intellectual property through this deal but was concerned about the impact of the merger in their overall business strategy.

Our Methodology:
  • Evaluation of the merging entities’ IP strength and potential capabilities
  • Deep-dive assessments into the compatibility aspect of the two firms to ensure cohesion
  • Analysis of Transactional costs relating to the merger
  • Descriptive understanding of the post-merger environment
Results:
  • Provided steps to retain control of major strategy centric processes to allay post-merger dissolution risks
  • Assessed Company’s exposure to post-merger impacts, and provided remedial solutions to combat such situations
  • Provision of safeguards to each entity during the transition to keep the process in control
  • Executed workshops to retain transparency during and after the merger

Related Insights

Portfolio Management
Portfolio Management

A small-Pharma client based in Israel involved DelveInsight to manage their portfolio of candidates indicated for various infectious diseases. [...]

View Case
Asset Prioritization
Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case
Pipeline Assessment
Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.